Drugplain

DYANAVEL XR 15 mg/1

amphetamine · TABLET, EXTENDED RELEASE · NextWave Pharmaceuticals, Inc

No Recall HistoryCurrently in Shortage
Plain English

Dyanavel XR is an extended-release amphetamine tablet taken by mouth to treat attention-deficit/hyperactivity disorder (ADHD). As a central nervous system stimulant, it works by increasing attention and decreasing impulsivity and hyperactivity in patients with ADHD.

Key Facts

Brand Name
DYANAVEL XR
Generic Name
amphetamine
NDC Code (Product)
24478-109
Manufacturer
NextWave Pharmaceuticals, Inc
Strength
15 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA210526
Drug Class
Central Nervous System Stimulant [EPC]
Marketing Start
11/04/2021

Recall History

No Recall History

Frequently Asked Questions

What is DYANAVEL XR used for?

Dyanavel XR is an extended-release amphetamine tablet taken by mouth to treat attention-deficit/hyperactivity disorder (ADHD). As a central nervous system stimulant, it works by increasing attention and decreasing impulsivity and hyperactivity in patients with ADHD.

Is DYANAVEL XR a controlled substance?

Yes, DYANAVEL XR is classified as CII under the DEA Controlled Substances Act.

What is the generic name for DYANAVEL XR?

The generic name for DYANAVEL XR is amphetamine. There are 12 other brand versions of amphetamine.

What is the NDC code for DYANAVEL XR 15 mg/1?

The NDC (National Drug Code) for DYANAVEL XR 15 mg/1 is 24478-109, listed by NextWave Pharmaceuticals, Inc.

Product NDC

24478-109

Package NDC

24478-109-01

Other Amphetamine Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)